Effective Use of Scientific Principles in The Courtroom: From Silicone to Talc and Beyond

Posted by on August 30, 2017

Nathan Schachtman is a lawyer with a deep respect and passion for the rigorous application of science in toxic tort and pharmaceutical and medical device litigation. Over the years, Nathan has played a significant role defending manufacturers of products as diverse as breast implants, welding rods, hormone replacement therapies, antidepressants, asbestos and silica. Nathan has
Read More

Opiate Litigation: What’s on the Horizon?

Posted by and on August 22, 2017

In 1996, James Campbell, a neurosurgeon at Johns Hopkins Medical School, gave a keynote speech at the American Pain Society’s annual conference. Campbell argued that hospitals must change their views on pain management by treating it as “The Fifth Vital Sign,” elevating it to the importance of collecting standard signs and symptoms (e.g., blood pressure, temperature, heart rate, and respiratory rate) as part of a standard medical exam.
Read More

How E-Cigarettes Are Viewed by Young Adults and Are They Effective?

Posted by on July 11, 2017

Maintaining a comprehensive and continuous awareness of the science is critical to any winning legal strategy – especially when it comes to cases involving products like electronic cigarettes (e-cigarettes) where the science is constantly changing and emerging. The best science-based defenses are those that are informed and constantly up-to-date on the science. E-cigarettes, sometimes referred
Read More

The Importance of Attributable Risk in Toxic Tort Litigation

Posted by on July 5, 2017

From a scientific standpoint, toxic tort cases, are about attributing a specific injury to a specific exposure. How can plaintiffs appropriately identify those individuals whose exposure was responsible for an injury? Or, alternatively, how can the defense identify those individuals whose exposure was not responsible for an injury. In epidemiology, this concept is assessed using
Read More

Using Genomics to Prevail in Toxic Tort Litigation

Posted by on June 19, 2017

Over the past several decades, genomic science revolutionized the practice of criminal law and is now in the process of transforming civil law. While the use of genetic science in criminal law tended to focus on relatively narrow issues, the genetic revolution in civil law is likely to lead to far wider ranging implications, including causation, foreseeability, compensation, ethics and risk management.
Read More

Presenting The Science Is Key In Talc Trials

Posted by and on June 13, 2017

Establishing a rigorous and reliable causal inference between an exposure and an adverse health outcome is one of the most difficult things to do in the health sciences. However, it is sometimes even more difficult to effectively and appropriately demonstrate that a causal relationship does not exist.
Read More

Streaming Video Testimony Sheds Light on Role of Science in California Talc Litigation

Posted by and on June 5, 2017

Every February 28th, India celebrates National Science Day in honor the  Indian physicist Sir Chandrashekhara Venkata, who discovered the Raman effect. The United States has no equivalent celebration, but “Science Days” have become a commonplace in complex state and federal Litigations, around the country.
Read More


Posted by on April 4, 2017

It is our experience that many attorneys and their teams struggle to keep up with new science in a systematic and organized fashion. However, we have also encountered scientific savvy firms that are up-to-date on the science and hard at work analyzing and developing new legal strategies based on the emerging science. This latter group is best-positioned to provide their clients with the best science-based defense.
Read More

Experts On The Experts: A Deep Dive Into The Make-or-Break Scientific Testimony Deciding Talc Powder Trials

Posted by on March 9, 2017

This article previously appeared on Courtroom View Network.
Read More

Will EU Regulatory Battles Over Endocrine Disruptors Translate to US Litigation?

Posted by on March 3, 2017

There is a battle raging in the European Union on an issue that is recognized in the US only by environmental scientists, policy wonks, and activists: the regulatory status of endocrine disrupting chemicals. As we have written before, this debate could have dramatic implications for litigation in the US. Such litigation could involve claims that
Read More